Clearbridge Health

Clearbridge Health's Philippine unit reports 8 cases of Covid-19

PRECISION medicine firm Clearbridge Health on Wednesday said eight people comprising patients and staff had tested positive for the novel coronavirus at its medical centre in Manila.

Clearbridge Health to distribute Biolidics spin-off's coronavirus test kits regionally

CATALIST-LISTED Clearbridge Health will be a non-exclusive regional distributor of its Catalist-listed spin-off Biolidics’ coronavirus antibody test kits, according to bourse filings.

Wild swings in Biolidics' shares after news of Covid-19 test kit deal

SHARES of Biolidics rapidly lost the bulk of their gains accumulated from recent days, after the medtech firm announced that Nasdaq-listed Aytu Bioscience will be the exclusive distributor of its...

Shares of medical suppliers soar with rise in virus cases

SINGAPORE'S healthcare plays, in particular medical-supply stocks, rallied on Wednesday even as the benchmark Straits Times Index fell 0.07 per cent to 2,550.04. This came as the number of...

Paving its way to deliver quality healthcare

IN the past year since Clearbridge Health was listed on the Singapore Exchange's Catalist board in Dec 2017, the healthcare group has been busy.

Clearbridge Health plans IPO spin-off for associate

CATALIST-listed medical technology company Clearbridge Health may bring an associate to an initial public offering (IPO), not long after its own bourse debut in December last year.

明策以配股方式凯利板上市 每股0.28元

  医疗保健公司明策集团(Clearbridge Health)的首次公开售股(IPO)将以配股方式,在凯利板上市。

  公司将以每股0.28元,配售8800万股,扣除开销后将筹得2140万元的的净收益。

市场再添医疗保健股 明策集团有意在凯利板上市

  医疗保健公司明策集团(Clearbridge Health)上周五提交招股说明书,打算在新加坡交易所凯利板上市,这将为本地股市再添一只医疗保健股。